CN Patent

CN103102359B — 嘧啶类化合物及其应用

Assigned to Jiangsu Simcere Pharmaceutical Co Ltd · Expires 2016-11-09 · 10y expired

What this patent protects

本发明涉及生物医药领域，具体涉及嘧啶类化合物及其应用，即通式(I)化合物及其药学上可接受的等价物或盐，本发明的化合物可以作为Janus激酶抑制剂应用于多种医药用途。

USPTO Abstract

本发明涉及生物医药领域，具体涉及嘧啶类化合物及其应用，即通式(I)化合物及其药学上可接受的等价物或盐，本发明的化合物可以作为Janus激酶抑制剂应用于多种医药用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103102359B
Jurisdiction
CN
Classification
—
Expires
2016-11-09
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Simcere Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.